ArticleCurrent developments in nutrition2026
How Well Is Ethiopia's Moderate Acute Malnutrition Program Implemented?
Article in Current developments in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The success of moderate acute malnutrition (MAM) management depends on adherence to protocol. Objectives: This study aimed to evaluate implementation fidelity of MAM management for children aged <5 y in Ethiopia through a retrospective chart review of 817 cases across 5 regions, representing diverse agroecologic zones. Methods: Data were collected from 101 health posts using systematic random sampling, and a structured checklist was used to extract data on sociodemographic status, protocol adherence, and follow-up care exposure. Data were managed digitally using Kobo Toolbox and analyzed with R version 20255.05.0, employing normality assessments, descriptive statistics, and nonparametric comparisons. Results: Admission protocols were well followed, with 95.7% of children admitted based on mid-upper arm circumference (MUAC) ≥11.5 cm and <12.5 cm. However, only 70.2% of children met the MUAC ≥12.5 cm discharge criteria, indicating weaker adherence at discharge. Follow-up care was limited; only 19% of children received deworming postadmission, and 38.6% of charts had incomplete deworming records. Most children (86.5%) attended the expected 3-8 visits, whereas 10.2% had >8 visits, predominantly in Afar and Sidama. Ready-to-use supplementary foods were the primary supplementary foods used in all regions. Regarding treatment duration, 84.4% of children remained in care for 3-16 wk, whereas 12.7% stayed beyond 16 wk, especially in Afar and Sidama. Target MUAC was achieved within 3-14 wk for 72.1% of children, but 22.6% required >14 wk, with prolonged recovery common in Afar (73.8% past 14 wk). Conclusions: Overall, admission fidelity was high, but gaps existed in discharge compliance, chart completeness, and follow-up care exposure. Regional disparities were pronounced in Afar and Sidama, where longer recovery times and higher visit frequencies were observed. Improving postadmission deworming and investigating regional differences are critical for enhancing MAM program effectiveness.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.